DEPARTMENT OF VIROLOGY

Size: px
Start display at page:

Download "DEPARTMENT OF VIROLOGY"

Transcription

1 DEPARTMENT OF VIROLOGY National Health Laboratory Services, KZN, Inkosi Albert Luthuli Central Hospital Nelson R Mandela School of Medicine, University of Kwa-Zulu Natal Introduction to the Virology of HIV Introduction This course covers the structure, replication, and immunological pathogenesis and laboratory aspects of HIV. Basic concepts in HIV Laboratory Surveillance, Vaccine Development and Antiretroviral Resistance will also be dealt with. Post exposure prophylaxis in the health care setting will be covered in detail. Objectives To facilitate the understanding of the basic science of HIV, this course will accomplish the following objectives: The structure and replication of HIV for future understanding of antiretroviral therapy including antiretroviral resistance. The pathogenesis of AIDS for future understanding of management of patients with HIV/AIDS. The role of laboratory assays in the surveillance of HIV/AIDS, diagnosis and clinical monitoring of patients. To develop an understanding of preventative strategies such as post exposure prophylaxis in health care and HIV vaccine development. Lectures Please note the following Appropriate attendance will facilitate accumulation of adequate knowledge and understanding. Attendees are expected to take good notes during the lecture. Reading before the lecture will enhance learning during the lecture Page 1 of 5

2 PROGRAMME: INTRODUCTION TO VIROLOGY OF HIV/AIDS DAY ONE 08H30 09H00 REGISTRATION 09H00 09H30 WELCOME 09H30 10H30 HIV structure and replication 10H30 11H00 TEA 11H00 12H00 BasicIimmunology 12H30 13H00 Pathogenesis 13H00 14H00 LUNCH 14H00 16H00 Laboratory Tests 16H00-16H30 CLOSURE DAY TWO 09H00 10H00 SMALL GROUP DISCUSSION: SMALL GROUP VALIDITY CASE STUDY 10H00 10H30 PLENARY : VALIDITY CASE STUDY 10H30 11H00 TEA 11H00 12H00 SMALL GROUP DISCUSSION: SMALL GROUP ARV Resistance 12H00 12H30 PLENARY: ARV Resistance 12H30 13H30 LUNCH 13H30 14H30 SMALL GROUP DISCUSSION:: SMALL GROUP HIV Vaccines 14H30 15H00 PLENARY: HIV Vaccines 15H00 15H30 CLOSURE DAY THREE 08H00 09H00 HIV Vaccines 09H00 10H00 ARV Resistance 10H00 10H30 TEA 10H30 11H15 POST EXPOSURE PROPHYLAXIS IN HEALTH CARE 11H15 12H00 Laboratory Tests 12H00 12H30 COURSE REVIEW Summary of Lecture Topics HIV structure and replication A brief introduction to HIV structure and replication including classification, genomic features and molecular epidemiology will facilitate understanding the impact of HIV on clinical management and vaccine development. Basic Immunology A brief introduction to normal immune reactions to viral infections will be covered to facilitate an understanding of the role of the immune system in the pathogenesis of AIDS. Page 2 of 5

3 Pathogenesis A brief introduction to the immune derangements which occur in HIV infection. Laboratory Diagnosis Methods in the diagnosis and monitoring of HIV infection will be covered. An overview of serological methods of diagnosing HIV infection i.e. ELISA and p24 antigen assays, molecular techniques eg PCR and viral load assays and their limitations. A brief introduction to validity of laboratory tests including an understanding of sensitivity, specificity and predictive values. HIV Vaccines The following will be covered after the Small Group Discussions Plenary: Different types of HIV vaccines Advantages and disadvantages of theses various vaccines Challenges in HIV Vaccine development. Current trends and strategies in the development of HIV vaccines Clinical trials of HIV vaccines and ethical considerations. ARV Resistance The following will be covered after the Small Group Assignment Discussions Plenary: Mechanisms of actions of the antiretroviral drugs Mechanisms involved in the development of drug resistance Patterns of drug resistance Laboratory techniques used to identify various resistance patterns. Strategies to overcome drug resistance Post-exposure Prophylaxis in Health Care An understanding of the rationale of post-exposure prophylaxis, and details regarding protocols and procedures in the management of such exposures. The role of the laboratory in HIV surveillance. The design and implementation of surveillance strategies including the interpretation and limitations of surveillance data. Small Group Discussions For maximum benefit all students must read the relevant literature before the Small Group Assignments. These will be undertaken in small groups on the second day. Each small group must spend one hour on each of the three topics. An insightful discussion of the topic must be evident during the plenary sessions. Topics 1. Laboratory validity is crucial in understanding clinical interpretation especially the causes of false positive and negative results. By using a case study from : The Laboratory Diagnosis of HIV Infection : SAMJ,February 2000;90( 2 ) and the attached explanatory notes, consider and discuss the following concepts: Sensitivity Page 3 of 5

4 Specificity Predictive Values 2. HIV has a high mutation rate due to the lack of proof reading mechanisms during replication. The use of antiretroviral drugs selects out mutations which continuously evolve resulting in antiretroviral drug resistance. Discuss this statement with emphasis on the following: Mechanisms of actions of the antiretroviral drugs Mechanisms involved in the development of drug resistance Patterns of drug resistance Laboratory techniques used to identify various resistance patterns. Strategies to overcome drug resistance 3. Since the eradication of smallpox due to a successful vaccination, a number of successful viral vaccines became available. There have been a few failures in viral vaccine development. Discuss HIV vaccines using the following as a guide: Different types of HIV vaccines Advantages and disadvantages of theses various vaccines Challenges in HIV Vaccine development. Current trends and strategies in the development of HIV vaccines Clinical trials of HIV vaccines and ethical considerations. Reading Compulsory Reading Below is a list of books and journals, which will be useful during the course. It is expected that reference be made to every item on the list during the course. These reading materials are provided in the course file to facilitate prior reading for the small group discussions. 1. HIV Medicine Ed Hoffmann.C, Rockstroh J.K and Kamps B.S.Flying Publisher Chapter 3: HIV Testing 2. Medical Management of HIV Infection. Bartlett, J.G and Gallant, J.E. John Hopkins University School of Medicine Chapter 2. Laboratory Diagnosis Chapter 4. Antiretroviral Therapy: Post Exposure Prophylaxis 3. Burgers,Wendy and Williamson,Carolyn. The challenges of HIV vaccine development and testing. Best Practice and Research Clinical Obstetrics and Gynaecology, 19(2): Elsevier Handbook of HIV Medicine. Ed. Douglas Wilson, Sudeshni Naidoo, Linda-Gail Bekker, Mark Cotton and Gary Maartens. Oxford University Press Southern Africa, 2002.Chapters 1 to 3. Page 4 of 5

5 5. A practical guide to HIV drug resistance and its implications for antiretroviral treatment strategies. Richman,D and Staszewski,S. International Medical Press Section 1 : the mechanisms and frequency of HIV drug resistance Background Reading Below are two reference books which will be useful during the course. It is not expected that reference is made to every item on the list during the course. 1. Fields Virology. 5 th ed. Edited by David M. Knipe, Peter M. Howley, Diane E. Griffin [et al.]. Philadelphia. Lippincott Williams & Wilkins, Harrison s Principles of Internal Medicine.15th ed. Edited by Eugene, Braunwald [et al.] New York. McGraw-Hill,2001. Self-evaluation Questions Answering the following questions will facilitate an evaluation on the knowledge accumulated during the course. These self assessment questions will be adequately approached using the compulsory reading list and knowledge acquired during the various lectures and small group discussions. 1. Using diagrams, describe the structure and replication of HIV. 2. Outline briefly the classification of HIV. 3. Explain briefly the genetic diversity of HIV. 4. Outline and explain the viral and host factor mechanisms involved in the pathogenesis of AIDS. 5. List the advantages and disadvantages of each of the laboratory assays used in the diagnosis and monitoring of HIV infection. These tests include: HIV ELISA Antibody and HIV ELISA Antigen HIV Rapid HIV DNA PCR HIV Viral Load CD-4/CD-8 Genotypic and Phenotypic Resistance 6. Describe briefly laboratory surveillance strategies in the epidemiology of HIV/AIDS. 7. Outline the clinical management of a health care worker who has sustained a deep needle stick injury from an HIV infected patient. 8. Outline and explain the current strategies in HIV Vaccine development. 9. Outline the strategies used to prevent antiretroviral resistance. Page 5 of 5

DEPARTMENT OF VIROLOGY

DEPARTMENT OF VIROLOGY DEPARTMENT OF VIROLOGY NELSON R MANDELA SCHOOL OF MEDICINE, UNIVERSITY OF KWAZULU-NATAL, and INKOSI ALBERT LUTHULI CENTRAL HOSPITAL, KZN BRANCH, NATIONAL HEALTH LABORATORY SERVICE Biomedscience III Virology

More information

Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation

Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation ISPUB.COM The Internet Journal of Infectious Diseases Volume 6 Number 2 Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation Y Graza,

More information

Extensive Kaposi's sarcoma in a HIV positive patient: A case report

Extensive Kaposi's sarcoma in a HIV positive patient: A case report ISPUB.COM The Internet Journal of Infectious Diseases Volume 7 Number 1 Extensive Kaposi's sarcoma in a HIV positive patient: A case report G Lopez, Y Graza Citation G Lopez, Y Graza.. The Internet Journal

More information

IAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB

IAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB IAS Conference Vienna 18 th to 23 rd July 2010 overview Paul Clift King s College Hospital/UK-CAB Overall Conference I c. 25,000 participants Covers everything HIV-related Several Pre-conferences: Faith,

More information

DEPARTMENT OF VIROLOGY, INKOSI ALBERT LUTHULI CENTRAL HOSPITAL, KZN BRANCH,NHLS

DEPARTMENT OF VIROLOGY, INKOSI ALBERT LUTHULI CENTRAL HOSPITAL, KZN BRANCH,NHLS DEPARTMENT OF VIROLOGY, INKOSI ALBERT LUTHULI CENTRAL HOSPITAL, KZN BRANCH,NHLS and Nelson R Mandela School of Medicine, University of KwaZuluNatal Acting Head of Department: Dr P Moodley Diagnostic services

More information

2016: The State of HIV & Hepatitis C in the District

2016: The State of HIV & Hepatitis C in the District 2016: The State of HIV & Hepatitis C in the District Travis A. Gayles, MD, PhD Chief Medical Officer, HIV/AIDS, Hepatitis, STD, and TB Administration Division Chief, STD and TB Control February 29, 2016

More information

Lahore University of Management Sciences. BIO 314- Microbiology and Virology (Spring 2018)

Lahore University of Management Sciences. BIO 314- Microbiology and Virology (Spring 2018) BIO 314- Microbiology and Virology (Spring 2018) Instructor Shaper Mirza Room No. 9-318A Office Hours TBA Email Shaper.Mirza@uth.tmc.edu ; shaper.mirza@lums.edu.pk Telephone 8413 Secretary/TA No TA Office

More information

Ethico-legal challenges in conducting HIV prevention trial research with adolescents: a South African case study of tool development

Ethico-legal challenges in conducting HIV prevention trial research with adolescents: a South African case study of tool development Ethico-legal challenges in conducting HIV prevention trial research with adolescents: a South African case study of tool development Melissa Wallace 1, Ann Strode 2, Cathy Slack 2, Agnes Ronan 1 and Linda-Gail

More information

CDC website:

CDC website: Hepatitis B virus CDC website: http://www.cdc.gov/ncidod/diseases/hepatitis/slideset/hep_b/slide_1.htm Relevance Key Features es of Hepatitis t B Virus 250 million people infected worldwide. In areas of

More information

The Biology of Viruses MMI / Biochem 575 SPRING 2015

The Biology of Viruses MMI / Biochem 575 SPRING 2015 The Biology of Viruses MMI / Biochem 575 SPRING 2015 INSTRUCTORS: Professor Paul Friesen Professor Andrew Mehle INTRODUCTION: The goal of Biology of Viruses (MMI/Biochem 575) is to introduce upperlevel

More information

Block 1. Immunology and Principles of Vaccination

Block 1. Immunology and Principles of Vaccination The Institute for International Cooperation in Animal Biologics (IICAB) is offering a eleven-day Veterinary Biologics Training Program beginning May 9, 2007 in Ames, Iowa. The course is sponsored by the

More information

CHS 476/676 AIDS: Psychosocial & Health Concerns Spring Semester

CHS 476/676 AIDS: Psychosocial & Health Concerns Spring Semester CHS 476/676 AIDS: Psychosocial & Health Concerns Spring Semester Times Location Instructor Kristen Clements-Nolle, PhD, MPH Office 216 Lombardi Building Office Hours by appointment Phone 682-7097 E-mail

More information

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART BIOE 301 LECTURE 10 MITALI BANERJEE A VACCINE FOR HIV HIV HAART Visit wikipedia.org and learn the mechanism of action of the five classes of antiretroviral drugs. (1) Reverse transcriptase inhibitors (RTIs)

More information

Minimum Standards for Laboratories in SADC Regions

Minimum Standards for Laboratories in SADC Regions Minimum Standards for Laboratories in SADC Regions Facilitator Guide Day 2 Minimum Laboratory Testing Standards: Diagnosis of HIV Infection at the NRL Table of Contents 1. Learner Information... 4 2. About

More information

Week 13 Microbiology II (Virology, HIV, Parasitology)

Week 13 Microbiology II (Virology, HIV, Parasitology) Week 13 Microbiology II (Virology, HIV, Parasitology) Welcome to Microbiology Week II This is your second week of microbiology. Hopefully, you have a strong handle of the basic principles of microbiology,

More information

Addressing key gaps in cure research through identification and treatment of hyperacute HIV infection in a resource-limited setting

Addressing key gaps in cure research through identification and treatment of hyperacute HIV infection in a resource-limited setting Addressing key gaps in cure research through identification and treatment of hyperacute HIV infection in a resource-limited setting Thumbi Ndung u, BVM, PhD KwaZulu-Natal Research Institute for Tuberculosis

More information

Date of study period: April 12 May 7, 2010 and August September, 2010

Date of study period: April 12 May 7, 2010 and August September, 2010 Classification of antiretroviral therapy failure using immunologic and clinical versus virologic monitoring in HIV-infected children and adolescents in Cambodia Date of study period: April 12 May 7, 2010

More information

IHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting

IHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting IHI Biomedical Sciences Group Joseph Mugasa, PhD, PD Stakeholders Meeting Jan 2013 Overview Biomedical group carries out a range of laboratory studies with the aim of understanding the pathogenesis, diagnosis

More information

SMALLPOX ERADICATION: DESTRUCTION OF VARIOLA VIRUS STOCKS. Report by the Secretariat CONTENTS

SMALLPOX ERADICATION: DESTRUCTION OF VARIOLA VIRUS STOCKS. Report by the Secretariat CONTENTS 14 June 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-sixth session Addis Ababa, 28 August 1 September 2006 Provisional agenda item 14 SMALLPOX ERADICATION: DESTRUCTION OF VARIOLA VIRUS STOCKS

More information

THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV

THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV THE IMPACT OF HLA CLASS I ON VIROLOGICAL OUTCOMES OF HBV Philippa Matthews Consultant in Infectious Diseases & Microbiology SUPPRESSION CO-EVOLUTION ESCAPE Host factors associated with the clinical course

More information

Syllabus: Principles of Virology

Syllabus: Principles of Virology Syllabus: Principles of Virology 1. Course Infromation: Title: Principles of Virology Number: F494 Credits: 3 Prerequisits: Biol 261 Location: To be determined 2. Instructor contact information: Karsten

More information

Professor of Medicine, Johns Hopkins Bloomberg School of Public Health; Director, Johns Hopkins Center for Global Health, Baltimore, MD

Professor of Medicine, Johns Hopkins Bloomberg School of Public Health; Director, Johns Hopkins Center for Global Health, Baltimore, MD Sunday 25 th August: Registration and Opening Ceremony. Registration 11.00 am 5.00 pm Opening Ceremony 6.30 pm 10.00 pm Master of Ceremonies: Ismae Whyms 6:30 pm National Anthem of Ariba 6:35 pm Opening

More information

HIV Drug Resistance (HIVDR)

HIV Drug Resistance (HIVDR) Technical Guidance Note for Round 10 Global Fund HIV Proposals HIV Drug Resistance (HIVDR) Rationale for including HIVDR prevention and assessment in the proposal June 2010 As access to ART services expands,

More information

Lahore University of Management Sciences. BIO314 Virology and Microbiology (Spring 2015)

Lahore University of Management Sciences. BIO314 Virology and Microbiology (Spring 2015) BIO314 Virology and Microbiology (Spring 2015) Instructor Room. Office Hours Email Telephone Secretary/TA TA Office Hours Course URL (if any) Shaper Mirza and Sadia Hamera Shaper.Mirza@uth.tmc.edu Course

More information

Transmission of XDR TB

Transmission of XDR TB Transmission of XDR TB Neel Gandhi, MD Tugela Ferry Care & Research Collaboration (TF CARES) Albert Einstein College of Medicine November 5, 2008 TF CARES Tugela Ferry Care and Research Collaboration Background

More information

Technical guidance for Round 9 Global Fund HIV proposals

Technical guidance for Round 9 Global Fund HIV proposals Technical guidance for Round 9 Global Fund HIV proposals Broad Area Service Delivery Area TREATMENT Prevention and assessment of HIV drug resistance (HIVDR) This technical brief provides key information

More information

HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS

HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS HIV AND HEPATITIS B/C CO-INFECTION IN KWAZULU-NATAL FROM 2002 TO 2010: A RETROSPECTIVE DATABASE ANALYSIS Submitted to: SCHOOL OF NURSING AND PUBLIC HEALTH UNIVERSITY OF KWAZULU-NATAL DURBAN SOUTH AFRICA

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

Lynn Morris. "Plan B"- bnabs for HIV prevention

Lynn Morris. Plan B- bnabs for HIV prevention "Plan B"- bnabs for HIV prevention Lynn Morris National Institute for Communicable Diseases, a division of the National Health Laboratory Service (NHLS) of South Africa, University of the Witwatersrand,

More information

Viral Genetics. BIT 220 Chapter 16

Viral Genetics. BIT 220 Chapter 16 Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse

More information

HIV Diagnostic Testing

HIV Diagnostic Testing In The name of God HIV Diagnostic Testing By : Dr. Shahzamani PhD of Medical virology Purpose of HIV Testing To identify asymptomatic individuals To diagnose HIV infection in those who practice high risk

More information

Tolerance vs. Resistance of infectious diseases. Lea Mösch& Hanna Schiff

Tolerance vs. Resistance of infectious diseases. Lea Mösch& Hanna Schiff Tolerance vs. Resistance of infectious diseases Lea Mösch& Hanna Schiff Introduction Definitions: Tolerance: the ability to limit the disease severity induced by a given parasite burden Resistance: the

More information

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Dr. Fausta Franklin Mosha (MD, MSc, MSc, PHD) Ministry of Health and Social Welfare 22 nd October

More information

Kaposi Sarcoma Causes, Risk Factors, and Prevention

Kaposi Sarcoma Causes, Risk Factors, and Prevention Kaposi Sarcoma Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn about the risk factors for Kaposi sarcoma.

More information

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON

VIRUSES. Biology Applications Control. David R. Harper. Garland Science Taylor & Francis Group NEW YORK AND LONDON VIRUSES Biology Applications Control David R. Harper GS Garland Science Taylor & Francis Group NEW YORK AND LONDON vii Chapter 1 Virus Structure and 2.2 VIRUS MORPHOLOGY 26 Infection 1 2.3 VIRAL CLASSIFICATION

More information

HIV Workforce Demand and Supply. E-Learning Technologies with Emphasis on the AETC National HIV Curriculum Project

HIV Workforce Demand and Supply. E-Learning Technologies with Emphasis on the AETC National HIV Curriculum Project 1 NORTHWEST AIDS EDUCATION AND TRAINING CENTER E-Learning Technologies with Emphasis on the AETC National HIV Curriculum Project David Spach, MD Principal Investigator, NWAETC Professor of Medicine, Division

More information

Challenges in the ART program and some solutions. Dr Francesca Conradie Southern African HIV Clinicians Society.

Challenges in the ART program and some solutions. Dr Francesca Conradie Southern African HIV Clinicians Society. Challenges in the ART program and some solutions Dr Francesca Conradie Southern African HIV Clinicians Society. Disclaimer This is not a teaching lecture on FDCs or the new guidelines. Retrospective and

More information

Vol. 6, No. 23 Summer 2011

Vol. 6, No. 23 Summer 2011 Vol. 6, No. 23 Summer 2011 IN THIS ISSUE: Snapshot Knowledge Hub activities to date, in numbers Knowledge Hub Calendar Find out about training workshops and other upcoming events Knowledge Hub in Review

More information

National Meeting on Precision Medicine and Cancer in

National Meeting on Precision Medicine and Cancer in National Meeting on Precision Medicine and Cancer in AMERICAN INDIAN & ALASKA NATIVE COMMUNITIES A Dialogue on Cancer Research Remarks by Congressman Tom Cole (OK-04) and Dr. Douglas Lowy, Acting Director

More information

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE

CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE CITY & HACKNEY ELIC EAST LONDON INTEGRATED CARE MANAGEMENT OF CHRONIC HEPATITIS B IN PRIMARY CARE Chronic Hepatitis B virus (HBV) is an important public health problem globally and a leading cause of liver

More information

GLOBAL AIDS MONITORING REPORT

GLOBAL AIDS MONITORING REPORT KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017

More information

HIV acute infections and elite controllers- what can we learn?

HIV acute infections and elite controllers- what can we learn? HIV acute infections and elite controllers- what can we learn? Thumbi Ndung u, BVM, PhD KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) and HIV Pathogenesis Programme (HPP), Doris Duke

More information

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions

Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of

More information

Challenges in the management of treatment-experienced patients in Sub- Saharan Africa: Clinical Perspective

Challenges in the management of treatment-experienced patients in Sub- Saharan Africa: Clinical Perspective Challenges in the management of treatment-experienced patients in Sub- Saharan Africa: Clinical Perspective Dr. Patricia Aladi Agaba Senior Lecturer, Department of Family Medicine, University of Jos Honorary

More information

SAUGA WORKSHOP DURBAN 2009

SAUGA WORKSHOP DURBAN 2009 SAUGA WORKSHOP DURBAN 2009 6 MARCH 2009: Inkosi Albert Luthuli Central Hospital 7 MARCH 2009: Sun Coast Casino INVITATION 2 ND ANNOUNCEMENT A warm welcome to the third biennial symposium of the South African

More information

Documented Analysis of HIV Care and Treatment Data. Workshop Report

Documented Analysis of HIV Care and Treatment Data. Workshop Report Documented Analysis of HIV Care and Treatment Data Workshop Report Dar es Salaam, Tanzania December 2017 Jim Todd Richelle Harklerode Paul Mee Funding for this work was provided by the Bill and Melinda

More information

The Biology of Viruses MMI / Biochem 575 SPRING 2015

The Biology of Viruses MMI / Biochem 575 SPRING 2015 The Biology of Viruses MMI / Biochem 575 SPRING 2015 INSTRUCTORS: Professor Paul Friesen Professor Andrew Mehle INTRODUCTION: The goal of Biology of Viruses (MMI/Biochem 575) is to introduce upper-level

More information

PHS 801 EPIDEMIOLOGY OF INFECTIOUS DISEASES (3 credits)

PHS 801 EPIDEMIOLOGY OF INFECTIOUS DISEASES (3 credits) PHS 801 EPIDEMIOLOGY OF INFECTIOUS DISEASES (3 credits) COURSE DESCRIPTION and OBJECTIVES This course is designed to provide an introduction to the principles and practice of infectious disease epidemiology.

More information

The Struggle with Infectious Disease. Lecture 6

The Struggle with Infectious Disease. Lecture 6 The Struggle with Infectious Disease Lecture 6 HIV/AIDS It is generally believed that: Human Immunodeficiency Virus --------- causes ------------- Acquired Immunodeficiency Syndrome History of HIV HIV

More information

Course specification

Course specification The University of Southern Queensland Course specification Description: Physiology and Pathophysiology 2 Subject NSC Cat-nbr 3630 Class 34429 Term 2, 2004 Mode EXT Units 1.00 Campus TWMBA Academic group:

More information

Progress against the HIV Epidemic: is the end in sight?

Progress against the HIV Epidemic: is the end in sight? Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern

More information

EACS HIV Summer School PRELIMINARY PROGRAMME

EACS HIV Summer School PRELIMINARY PROGRAMME EACS HIV Summer School Thursday, August 30, 2018 Monday, September 3, 2018 Montpellier, France This 5-day residential course is designed for clinicians experienced in HIV management who want an update

More information

IHI South Africa Quarterly Report

IHI South Africa Quarterly Report IHI South Africa Quarterly Report September1 st November 31 st 2010 Executive Summary The Institute for Healthcare Improvement s South African country programme was started in 2005. Over the past five

More information

43. Guidelines on Needle stick Injury

43. Guidelines on Needle stick Injury 43. Guidelines on Needle stick Injury The following information is abstracted from the South African Department of Health guidelines entitled: Management of Occupational Exposure to the Human Immunodeficiency

More information

Richard A. Jenkins PhD Prevention Research Branch, NIDA July 19, 2017 Fordham University

Richard A. Jenkins PhD Prevention Research Branch, NIDA July 19, 2017 Fordham University Richard A. Jenkins PhD Prevention Research Branch, NIDA jenkinsri@mail.nih.gov July 19, 2017 Fordham University So, what s the next step An efficacy-type trial (R01)? A pilot intervention trial (R34)?

More information

Student Immunisation Record Faculty of Medicine. Section 1: Information. Notes

Student Immunisation Record Faculty of Medicine. Section 1: Information. Notes Student Immunisation Record Faculty of Section 1: Information Students enrolled in programs offered by the Faculty of are REQUIRED to provide evidence of their immunisation status for the diseases listed

More information

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS Acquired immunodeficiency syndrome (AIDS ) is an infectious disease caused by a retrovirus, the human immunodeficiency virus(hiv). AIDS is

More information

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

PhD THESIS SUMMARY ANATOMO-CLINICAL AND LABORATORY STUDIES IN OUTBREAKS OF BLUETONGUE IN ROMANIA

PhD THESIS SUMMARY ANATOMO-CLINICAL AND LABORATORY STUDIES IN OUTBREAKS OF BLUETONGUE IN ROMANIA PhD THESIS SUMMARY ANATOMO-CLINICAL AND LABORATORY STUDIES IN OUTBREAKS OF BLUETONGUE IN ROMANIA PhD STUDENT: MIHAIL CLAUDIU DIACONU SCIENTIFIC COORDINATOR: GABRIEL PREDOI, DVM, PhD, PROFESSOR Key words:

More information

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016

CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 MORNING PLENARY LECTURES: LIBERTY BALLROOM (M4) 9:00 9:15 AM Welcome and Introductions Conference Co-Chairs: Laura W. Cheever, MD, ScM; Michael S.

More information

Minimum Standards for Laboratories in SADC Regions

Minimum Standards for Laboratories in SADC Regions Minimum Standards for Laboratories in SADC Regions Participant Guide Day 2 Minimum Laboratory Testing Standards: Diagnosis of HIV Infection at the NRL Table of Contents 1. Learner Information... 4 2. About

More information

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis

RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis RNA PCR, Proviral DNA and Emerging Trends in Infant HIV Diagnosis 1 B R E N D A N M C M U L L A N I N F E C T I O U S D I S E A S E S, S Y D N E Y C H I L D R E N S H O S P I T A L S C H O O L O F W O

More information

CHAPTER 18: Immune System

CHAPTER 18: Immune System CHAPTER 18: Immune System 1. What are four characteristics of the specific immune system? a. b. c. d. 2. List the two main types of defense mechanisms and briefly describe features of each. 3. Give examples

More information

Immunodeficiencies HIV/AIDS

Immunodeficiencies HIV/AIDS Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement

More information

South African Guidelines for the Safe Use of. Dr. Oscar Radebe

South African Guidelines for the Safe Use of. Dr. Oscar Radebe South African Guidelines for the Safe Use of PrEP in MSM Dr. Oscar Radebe Background Globally MSM(men who have sex with men) have been disproportionately at high risk of HIV transmission. Biological &

More information

New Strategiesfor HIV/AIDS Surveillancein Resource-ConstrainedCountries

New Strategiesfor HIV/AIDS Surveillancein Resource-ConstrainedCountries New Strategiesfor HIV/AIDS Surveillancein Resource-ConstrainedCountries AddisAbaba,Ethiopia 26-29January2004 New Strategies for HIV/AIDS Surveillance in Resource-Constrained Countries Addis Ababa, Ethiopia

More information

4 th WHO/AFRO-CDC JOINT MEETING OF THE REGIONAL HIV/AIDS/STI PUBLIC HEALTH LABORATORIES NETWORK. Addis Ababa Ethiopia, November 2006

4 th WHO/AFRO-CDC JOINT MEETING OF THE REGIONAL HIV/AIDS/STI PUBLIC HEALTH LABORATORIES NETWORK. Addis Ababa Ethiopia, November 2006 4 th WHO/AFRO-CDC JOINT MEETING OF THE REGIONAL HIV/AIDS/STI PUBLIC HEALTH Addis Ababa Ethiopia, 7-8-9 November 2006 Enhancing Quality and Access of Laboratory Services TUESDAY 7 November 2006 08.00-09.00

More information

SURVEILLANCE TECHNICAL

SURVEILLANCE TECHNICAL CHAPTER 5 SURVEILLANCE TECHNICAL ASPECTS 55 Protect - detect - protect Polio eradication strategies can be summed up as protect and detect protect children against polio by vaccinating them, and detect

More information

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University

More information

"Development and Clinical Progress. of DNA Vaccines" Program

Development and Clinical Progress. of DNA Vaccines Program Paul-Ehrlich-Institut International Conference "Development and Clinical Progress of DNA Vaccines" Paul-Ehrlich-Institut, Langen, Germany October 6-8, 1999 Program CBER/FDA INTERNATIONAL ASSOCIATION FOR

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

Working Document on Monitoring and Evaluating of National ART Programmes in the Rapid Scale-up to 3 by 5

Working Document on Monitoring and Evaluating of National ART Programmes in the Rapid Scale-up to 3 by 5 Working Document on Monitoring and Evaluating of National ART Programmes in the Rapid Scale-up to 3 by 5 Introduction Currently, five to six million people infected with HIV in the developing world need

More information

EPIDEMIOLOGICAL NETWORK PLANNING MEETING AND CONTINENTAL CONSULTATION FOR DRUG DEMAND REDUCTION FOCAL POINTS. Draft Agenda

EPIDEMIOLOGICAL NETWORK PLANNING MEETING AND CONTINENTAL CONSULTATION FOR DRUG DEMAND REDUCTION FOCAL POINTS. Draft Agenda AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone : 011-551 7700 Fax : 011-551 7844 website : www. africa-union.org CONTINENTAL EXPERTS MEETING CAPE TOWN SOUTH

More information

Technical Guidance Note for Round 11 Global Fund HIV Proposals

Technical Guidance Note for Round 11 Global Fund HIV Proposals Technical Guidance Note for Round 11 Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including HIVDR prevention and assessment in the proposal Situation analysis As access

More information

Prevention of Hepatitis in risk groups and hepatitis and HIV in Albania. Ass.Prof. Najada COMO

Prevention of Hepatitis in risk groups and hepatitis and HIV in Albania. Ass.Prof. Najada COMO VHPB Meeting Prevention of Hepatitis in risk groups and hepatitis and HIV in Albania Ass.Prof. Najada COMO Infectious Diseases Clinic UHC Mother Theresa Tirane Rogner, Tirane, Albania, 27 28 October 2016

More information

Agenda. KIGALI Serena Hotel, 7 th 8 th June, 2018

Agenda. KIGALI Serena Hotel, 7 th 8 th June, 2018 1 st International Steering Committee meeting 7 th 8 th June, 2018 Kigali Serena Hotel, Kigali, Rwanda Agenda KIGALI Serena Hotel, 7 th 8 th June, 2018 Objectives: Finalize the Theme and objectives of

More information

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know

Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Diagnosis and Initial Management of HIV/AIDS: What the Primary Care Provider Should Know Carolyn K. Burr, EdD, RN Co-Clinical Director Deputy Director François-Xavier Bagnoud Center December 17 th, 2013

More information

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN

JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim

More information

Background to the Discovery Foundation

Background to the Discovery Foundation 1 Discovery Foundation What is the Discovery Foundation doing to increase the quality and quantity of PhDs in the clinical sciences? Dr Maurice Goodman Background to the Discovery Foundation 2 Set up in

More information

Atul Humar, MD, MSc Director, Transplant Program, University Health Network, University of Toronto

Atul Humar, MD, MSc Director, Transplant Program, University Health Network, University of Toronto TIME PROGRAM TITLE 7:30 8:15 Registration and Continental Breakfast 8:15 8:30 Welcoming Remarks TOPIC: VIRUSES Session Chair: Shahid Husain CMV: What is New, What s Hot Atul Humar, MD, MSc Director, Transplant

More information

7th International Symposium on Hepatitis Care in Substance Users

7th International Symposium on Hepatitis Care in Substance Users 7th International Symposium on Hepatitis Care in Substance Users The Abstract Guidelines must be followed as closely as possible in order for your presentation to be considered. Please ensure that the

More information

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B

Section Lectures: Immunology/Virology Time: 9:00 am 10:00 am LRC 105 A & B Section Director: Cliff Bellone, Ph.D. Office: Doisy Hall - R 405 Phone: 577-8449 E-Mail: bellonec@slu.edu Lecturers: James Swierkosz, Ph.D. Office: Medical School Rm. 412 Phone: 577-8430 E-Mail: swierkoszje@slu.edu

More information

Study of Hepatitis B Virus and Hepatitis C Virus Co-infection in Human Immunodeficiency Virus Seropositive Cases Jose P. Augustine

Study of Hepatitis B Virus and Hepatitis C Virus Co-infection in Human Immunodeficiency Virus Seropositive Cases Jose P. Augustine Study of Hepatitis B Virus and Hepatitis C Virus Co-infection in Human Immunodeficiency Virus Seropositive Cases Jose P. Augustine Assistant Professor, Department of Microbiology, Sree narayana Institute

More information

Background HPV causes virtually all cervical cancers HPV-16, Integration of viral oncogenes E6 and E7 Relationship between HPV and cervical cancer wou

Background HPV causes virtually all cervical cancers HPV-16, Integration of viral oncogenes E6 and E7 Relationship between HPV and cervical cancer wou Case-Control Control Study of Human Papillomavirus avi and Oropharyngeal Cancer D Souza, DSouza, et al. NEJM, May 2007 Tony Sung Julia Beaver Journal Club September 9, 2009 Background HPV causes virtually

More information

The Hepatitis B-e antigen-positive

The Hepatitis B-e antigen-positive The Hepatitis B-e antigen-positive Dental Student Developing an Equitable Policy Hepatitis B Virus Serology 1 HBsAg A protein on the surface of HBV; it can be detected in high levels in serum during acute

More information

THE EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN NSW CHILDREN,

THE EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN NSW CHILDREN, THE EPIDEMIOLOGY OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN NSW CHILDREN, 1992 1997 Susan Lister * and Peter McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable

More information

PART A. True/False. Indicate in the space whether each of the following statements are true or false.

PART A. True/False. Indicate in the space whether each of the following statements are true or false. MCB 55 Plagues and Pandemics Midterm I Practice questions Read each question carefully. All the questions can be answered briefly, in the space allotted. PART A. True/False. Indicate in the space whether

More information

Study Guide 23, 24 & 47

Study Guide 23, 24 & 47 Study Guide 23, 24 & 47 STUDY GUIDE SECTION 23-3 Bacteria and Humans Name Period Date 1. One bacterial disease that is transmitted by contaminated drinking water is a. Lyme disease b. gonorrhea c. tuberculosis

More information

Table of Contents (continued)

Table of Contents (continued) Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

Nursing and Midwifery students only. Section 1: Information

Nursing and Midwifery students only. Section 1: Information Nursing and Midwifery students only. Section 1: Information Students enrolled in programs offered by our School are REQUIRED to provide evidence of their immunisation status for the diseases listed in

More information

Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs

Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Module Time Learning Objectives To provide the participants with the basic concepts of

More information

DISCLOSURES. I have no actual or potential conflicts of interest in this presentation.

DISCLOSURES. I have no actual or potential conflicts of interest in this presentation. OVERVIEW ON MEASLES Oneka B. Marriott, DO, MPH, FAAP, FACOP Assistant Professor of Pediatrics and Public Health Nova Southeastern University College of Osteopathic Medicine Presentation to FSACOFP Annual

More information

How do we measure HIV drug resistance. Monique Nijhuis

How do we measure HIV drug resistance. Monique Nijhuis How do we measure HIV drug resistance Monique Nijhuis Measure HIV drug resistance Genotypic resistance test vs Phenotypic resistance test Measure HIV drug resistance Genotypic resistance test vs Phenotypic

More information

UNRAVELING THE MYSTERY BEHIND HIV/AIDS

UNRAVELING THE MYSTERY BEHIND HIV/AIDS PRESS RELEASE 3 MAR 2010 UNRAVELING THE MYSTERY BEHIND HIV/AIDS New findings by Nobel Laureate shed light on the elusive AIDS virus and may lead to effective HIV vaccine development 1. Professor Francoise

More information

Requirements of the Terrestrial Code for FMD surveillance. Dr David Paton Dr Gideon Brückner

Requirements of the Terrestrial Code for FMD surveillance. Dr David Paton Dr Gideon Brückner Requirements of the Terrestrial Code for FMD surveillance Dr David Paton Dr Gideon Brückner 1 Surveillance Close observation Origin of the word: Early 19th century: from French, from sur- over + veiller

More information

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND... 8 April 2014 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH PROGRAMME SUBCOMMITTEE Sixty-fourth session Brazzaville, Republic of Congo, 9 11 June 2014 Provisional agenda item 6 VIRAL HEPATITIS: SITUATION

More information

2*Day Stuttering Conference Fluency Disorders and Subtypes Thursday 24 October 2013 Friday 25 October 2013

2*Day Stuttering Conference Fluency Disorders and Subtypes Thursday 24 October 2013 Friday 25 October 2013 2*Day Stuttering Conference Fluency Disorders and Subtypes Thursday 24 October 2013 Friday 25 October 2013 Organised by The Department of Speech-Language Pathology and Audiology, University of Pretoria

More information

Day Seven: Helping HIV Affected Children and Orphans

Day Seven: Helping HIV Affected Children and Orphans Note: This training material is continually being evaluated and updated to reflect current needs and best practices therefore it should be viewed as work in progress. Any person, organization, or institution

More information